Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, do...

por Murakami, Kazunari, Sakurai, Yuuichi, Shiino, Madoka, Funao, Nobuo, Nishimura, Akira, Asaka, Masahiro
Publicado 2016

Pharmacokinetic Drug–Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese Men

por Sakurai, Yuuichi, Shiino, Madoka, Horii, Sayako, Okamoto, Hiroyuki, Nakamura, Koki, Nishimura, Akira, Sakata, Yukikuni
Publicado 2016

Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicen...

por Kinoshita, Yoshikazu, Sakurai, Yuuichi, Shiino, Madoka, Kudou, Kentaro, Nishimura, Akira, Miyagi, Takuya, Iwakiri, Katsuhiko, Umegaki, Eiji, Ashida, Kiyoshi
Publicado 2016

A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis

por Iwakiri, Katsuhiko, Sakurai, Yuuichi, Shiino, Madoka, Okamoto, Hiroyuki, Kudou, Kentaro, Nishimura, Akira, Hiramatsu, Naoki, Umegaki, Eiji, Ashida, Kiyoshi
Publicado 2017